A Phase 1B, dose-finding study of Ruxolitinib plus Panobinostat in patients with primary myelofibrosis (MF), post–Polycythemia Vera MF (PPV-MF), or post-Essential (PET-MF) Thrombocythemia MF - Harrison, C; Kiladjan, J J; Passamonti, F (2012)
(EHA Annual Meeting Abstracts)